Virbagen Omega
10 MU
EU/2/01/030/003
Virbac S.A., Francija
QL03AB
dogs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Recombinant feline interferon Omega
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Virbac S.A., Francija
Date of authorisation/renewal:
20-Nov-2006
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/01/030/003
10 MU
2
Flakons, 1 flakons
-
Purevax RCP FeLV
-
EU/2/04/048/004
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AJ03
cats
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Recombinant Canarypox virus,Attenuated feline rhinotracheitis herpesvirus,Inactivated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal:
23-Feb-2005
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/04/048/004
1 devas/flakonā
50
Stikla flakons, 1 deva
-
Innovax-ND-IBD
-
EU/2/17/213/001
Intervet International B.V., Nīderlande
QI01AD16
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
suspension and solvent for suspension for injection
International name (active substance):
Cell-associated live recombinant turkey herpesvirus (strain HVP360)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International B.V., Nīderlande
Date of authorisation/renewal:
21-Aug-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/213/001
200
Stikla ampula, 2000 deva
-
Daxocox
100 mg
EU/2/21/270/031
Ecuphar NV, Beļģija
QM01AH95
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Enflicoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Lelypharma B.V., Nīderlande
Date of authorisation/renewal:
20-Apr-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/270/031
100 mg
3
Blisteris, 4 tablete
-
Lotilaner Elanco
112 mg
EU/2/22/288/003
Elanco GmbH, Vācija
QP53BE04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S., Francija
Date of authorisation/renewal:
13-Sep-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/22/288/003
112 mg
1
Blisteris, 1 tablete
-
Lotilaner Elanco
225 mg
EU/2/22/288/006
Elanco GmbH, Vācija
QP53BE04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S., Francija
Date of authorisation/renewal:
13-Sep-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/22/288/006
225 mg
1
Blisteris, 3 tablete
-
Bravecto Plus
-
EU/2/18/224/005
Intervet International B.V., Nīderlande
QP54AB52
cats
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Moxidectin,Fluralaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet UK Ltd, Lielbritānija
Date of authorisation/renewal:
08-May-2018
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/18/224/005
1
PP/Al pipete, 1,79 ml
-
Zolvix
25 mg/ml
EU/2/09/101/002
Elanco GmbH, Vācija
QP52AX09
sheep
Vairāk
Medicinal product information
Pharmaceutical form:
solution for oral use
International name (active substance):
Monepantel
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
Date of authorisation/renewal:
03-Nov-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/09/101/002
25 mg/ml
1
Plastmasas pudele, 0,25 l
-
Stronghold Plus
-
EU/2/16/204/005
Zoetis Belgium S.A., Beļģija
QP54AA55
cats
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Selamectin,Sarolaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
07-Dec-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/16/204/005
3
Polipropilēna pipete, 1 ml
-
Clomicalm 5 mg
5 mg
EU/2/98/007/001
VIRBAC, Francija
QN06AA04
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Clomipramine hydrochloride
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
10-Apr-2010
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/98/007/001
5 mg
1
ABPE pudele, 30 tablete
-
Bovela
-
EU/2/14/176/006
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI02AD02
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health USA Inc., ASV
Date of authorisation/renewal:
21-Dec-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/176/006
4
Stikla flakons, 10 deva
-
Simparica
80 mg/tabl.
EU/2/15/191/013
Zoetis Belgium S.A., Beļģija
QP53BE03
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Sarolaner
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
12-Aug-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/15/191/013
1
Al/Al blisteris, 1 tablete
-
Lotilaner/Milbemycin Elanco 112,5 mg/4,22 mg
-
EU/2/26/361/008
Elanco GmbH, Vācija
QP54AB51
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Lotilaner, Milbemycin oxime
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija
Date of authorisation/renewal:
25-Feb-2026
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/26/361/008
18
Al/Al blisteris, 1 tablete
-
BLUEVAC-3
-
EU/2/24/331/002
CZ Vaccines S.A.U., Spānija
QI04AA02
cattle; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023, inactivated
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
20-Feb-2025
Marketing authorisation valid until:
19-Feb-2026
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/331/002
1
ABPE pudele, 100 ml
-
Palladia
50 mg
EU/2/09/100/003
Zoetis Belgium S.A., Beļģija
QL01XE91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Toceranib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Pfizer Italia s.r.l., Itālija
Date of authorisation/renewal:
22-Sep-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/09/100/003
50 mg
20
PVH/Al blisteris, 1 tablete
-
Simparica Trio
mg
EU/2/19/243/002
Zoetis Belgium S.A., Beļģija
QP54AB52
Dogs 1,25 – 2,5 kg
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Sarolaner, Moxidectin, Pyrantel embonate
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Corden Pharma GmbH, Vācija
Date of authorisation/renewal:
17-Sep-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/19/243/002
3
Alumīnija folija blisteris, 1 tablete
-
Innovax-ND-H5
-
EU/2/24/315/002
Intervet International B.V., Nīderlande
QI01AD
chickens; embryonated chicken eggs
Vairāk
Medicinal product information
Pharmaceutical form:
concentrate and solvent for suspension for injection
International name (active substance):
Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5, Live
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
22-May-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/315/002
2 ml
1
Stikla ampula (2ml), 4000 deva
-
Suvaxyn PRRS MLV
-
EU/2/17/215/002
Zoetis Belgium S.A., Beļģija
QI09AD03
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Modified live porcine reproductive and respiratory syndrome virus, strain 96V198
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal:
15-Jul-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/17/215/002
1
Stikla flakons, 50 deva
-
Purevax Rabies
-
EU/2/10/117/002
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AX
cats
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Rabies recombinant canarypox virus (vCP65)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
MERIAL, Francija
Date of authorisation/renewal:
02-Dec-2015
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/117/002
1 ml/deva
50
Flakons, 1 ml
-
Advocate Spot-on šķīdums maziem suņiem
-
EU/2/03/039/042
Bayer Animal Health , Vācija
QP54AB52
small dogs
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Moxidectin,Imidacloprid
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
16-Jul-2007
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/03/039/042
12
Pipete, 0,4 ml
-